Y-box binding protein 1 regulates ox-LDL mediated inflammatory responses and lipid uptake in macrophages.


Journal

Free radical biology & medicine
ISSN: 1873-4596
Titre abrégé: Free Radic Biol Med
Pays: United States
ID NLM: 8709159

Informations de publication

Date de publication:
09 2019
Historique:
received: 14 02 2019
revised: 19 05 2019
accepted: 29 05 2019
pubmed: 4 6 2019
medline: 14 7 2020
entrez: 3 6 2019
Statut: ppublish

Résumé

Y-box protein 1 (YB1) is a key regulator of inflammatory mediators. However, the roles of YB1 in oxidized low-density lipoprotein (ox-LDL)-induced macrophage inflammation and lipid uptake remain less understood. Thus, we explored the roles of YB1 in ox-LDL-induced macrophage inflammation and lipid uptake and its underlying molecular mechanisms. An ox-LDL-induced atherosclerosis (AS) model was used in this study. Western blotting, RT-PCR, immunofluorescence, ELISA, dil-ox-LDL staining, a dual-luciferase reporter assay, RNA-binding protein immunoprecipitation (RIP) and in vivo experiments were used to detect each target. ox-LDL downregulates YB1 expression in THP-1-derived macrophages and human monocyte-derived macrophages (hMDMs) via the NF-κB pathway. Downregulation of YB1 is facilitated by lipid uptake in macrophages, and CD36 is involved in this process. Furthermore, YB1 suppresses CD36 protein levels by directly binding to the coding sequence of the CD36 gene to promote CD36 mRNA decay but does not affect its mRNA transcription. Additionally, YB1 knockdown enhances the inflammatory response and lipid deposition via the NF-κB pathway in vivo. ox-LDL decreases YB1 expression in macrophages, resulting in enhanced inflammatory responses by affecting NF-κB and facilitating lipid uptake by promoting scavenger receptor CD36 mRNA decay.

Identifiants

pubmed: 31153975
pii: S0891-5849(19)30249-7
doi: 10.1016/j.freeradbiomed.2019.05.032
pii:
doi:

Substances chimiques

CD36 Antigens 0
Lipoproteins, LDL 0
NF-kappa B p50 Subunit 0
NFKB1 protein, human 0
Y-Box-Binding Protein 1 0
YBX1 protein, human 0
oxidized low density lipoprotein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-20

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Xueming Cao (X)

Department of Cardiology, Henan Provincial Key Lab for Control of Coronary Heart Disease, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou University People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, 450003, China.

Na Zhu (N)

Department of Health Management, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, 450003, China.

Li Li (L)

Department of Scientific Research and Discipline Construction, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, 450003, China.

Yuwei Zhang (Y)

Medical Genetic Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, 450003, China.

Yan Chen (Y)

Department of Cardiology, Henan Provincial Key Lab for Control of Coronary Heart Disease, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou University People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, 450003, China.

Jing Zhang (J)

Department of Cardiology, Henan Provincial Key Lab for Control of Coronary Heart Disease, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou University People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, 450003, China.

Jiang Li (J)

Department of Cardiology, Henan Provincial Key Lab for Control of Coronary Heart Disease, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou University People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, 450003, China.

Chuanyu Gao (C)

Department of Cardiology, Henan Provincial Key Lab for Control of Coronary Heart Disease, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou University People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, 450003, China. Electronic address: hncxm2007@henu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH